Abstract:Background: High drug costs due to supplier-induced demand (SID) obstruct healthcare accessibility in China. Drug prescriptions can generate markup-related profits, and the low prices of other medical services can lead to labor-force underestimations; therefore, physicians are keen to prescribe drugs rather than services. Thus, in China, a public hospital reform has been instituted to cancel markups and increase service prices. Methods: A retrospective pre/post-reform study was conducted in ZJ province to assess the impact of the reform on healthcare expenditures and utilization, ultimately to inform policy development and decision-making. The main indicators are healthcare expenditures and utilization. Results: Post-reform, drug expenditures per visit decreased by 8.2% and 15.36% in outpatient and inpatient care, respectively; service expenditures per visit increased by 23.03% and 27.69% in outpatient and inpatient care, respectively. Drug utilization per visit increased by 5.58% in outpatient care and underwent no significant change in inpatient care. Both were lower than the theoretical drug-utilization level, which may move along the demand curve because of patient-initiated demand (PID); this indicates that SID-promoted drug utilization may decrease. Finally, service utilization per visit increased by 6% in outpatient care and by 13.10% in inpatient care; both were higher than the theoretical level moving along the demand curve, and this indicates that SID-promoted service utilization may increase. Conclusion: The reform reduces drug-prescription profits by eliminating drug markups; additionally, it compensates for service costs by increasing service prices. Post-reform, the SID of drug prescriptions decreased, which may reduce drug-resource waste. The SID of services increased, with potentially positive and negative effects: accessibility to services may be promoted when physicians provide more services, but the risk of resource waste may also increase. This warrants further research. It is recommended that comprehensive measures that control SID and promote physician enthusiasm be carried out concurrently.

Drug using survey in 12 hospitals in 7 provinces

Analysis on the Trend of Drug Use in 22 Hospitals in Hangzhou Region During the Period from 2002 to 2004

The Situation of Drugs Used in the Hospitals of Shanghai District During the Period of 1999-2001

The Situation of Drugs Used in the Hospitals of Shanghai District During the Period of 2000-2002

Impact on Hospital Medicine After Adjusting the Drug Pricing Method

A Description of Outpatient Drug Use in Rural China: Evidence of Differences Due to Insurance Coverage.

Study of the Antibacterials Purchase Price Trends from 1996 to 2005 of Beijing Sample Hospitals

Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China

Investigation and Survey of Essential Drugs Provision and Use in Primary Health Care Institutions from Some Areas in China

Effects of Different Mark-Up Drug Policies on Drug-Related Expenditures in Tertiary Public Hospitals: an Interrupted Time Series Study in Shanghai, China, 2015-2018.

Cause Analysis of High Price Differences Drugs Before and After the Deregulation of Drug Price Control: Empirical Study with big data on drug price data of 16 provinces in China

Changes of Drug Economic Burden of Patients in Shanghai after Implementation of National Essential Drug System

Intended and Unintended Impacts of Price Changes for Drugs and Medical Services: Evidence from China.

Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province

The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China

Comparative analysis on the price of essential medicines:Based on the sample survey of primary health care institutions and pharmacies in 18 provinces

An evidence-base study on drug price in Shanghai

Analysis and discussion on the pharmaceutical centralized procurement implementation — a case study of a large provincial hospital in China

Demand analysis of drugs outside the list of national essential medicines and Shanghai supplementary drugs in the community health centers of Shanghai

The Effect of the Implementation of Low Price Medicine Policy on Medicine Price in China: A Retrospective Study

Cost and Amount of Consumption of Four Sorts of Drugs in Shanghai in the Years 1994～ 1999